Biotronwave, page-93

SARS-CoV-2 envelope protein causes acute respiratory distress syndrome
(ARDS)-like pathological damage and constitutes an antiviral target

Short title: Envelope protein of SARS-CoV-2 forms offensive cation channels

https://www.biorxiv.org/content/10.1101/2020.06.27.174953v1.full.pdf

The SARS-CoV-2 envelope (2-E) protein is the smallest major structural protein but has been largely neglected, in contrast to other major structural proteins such as the spike (S) protein...Here, we showed that the 2-E protein forms a cation channel that is lethal to host cells and inhibition of the 2-E channel is new antiviral strategy....

Study out of China yesterday regarding the potential of E-Protein as a treatment for Covid-19, although BIT225 is not mentioned, it would be bloody good if the Chinese Govt or large Pharmas in China (who are increasingly investing big on drug companies) decides to have a crack at BIT225.

BIT's inclusion in the AIDS and Covid Conference may not be coming at a better time for BIT!